top of page
This is the message to your visitors online. What is the message?
Infextious Therapeutic is an AJK Biopharmaceutical company founded in 2018. Its mission is combating the life–threatening infectious disease using a novel Cyclic Peptide platform. Its focus is on the clinical development of novel anti-infective therapeutic drugs with emphasis on developing antiviral peptides against SARS-COV2, herpes simplex (HSV), and human papilloma (HPV) viruses, Broad-spectrum antimicrobial peptides with activity against multi-drug resistant bacteria, and Antifungal peptides against Onychomycosis.
04.23.2020 – Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)
09.02.2020 – Chapman Researchers Advance the Fight Against Antibiotic Resistance
bottom of page